Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132043) titled 'Neutrophil Piezo1 Expression for Early Diagnosis and Prognosis Evaluation of Sepsis-Associated ARDS: A Clinical Observational Study' on Sept. 9.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Fuzhou University Affiliated Provincial Hospital
Condition:
Sepsis
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-09
Target Sample Size: Sepsis combined with ARDS / Sepsis without ARDS observation group:90;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=325643
Published by HT Digital Content Services...